-
A Multicenter Randomized Double-Blind Placebo-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of BIIB059 in Adult Participants With Active Systemic Lupus Erythematosus Receiving Background Non-Biologic Lupus Standard of Care
The purpose of the study is to investigate if the investigational study drug BIIB059 can reduce disease activity and inflammation in people with active systemic ... -
Pfizer Phase 3 Respiratory Syncytial Virus (RSV) Clinical Trial
RSV is a viral infection that can cause severe respiratory disease in infants and adults, especially in patients with certain health conditions that put them ...